# Adenosine

NDC: 67457-856
Generic name: adenosine
Labeler / Manufacturer: Mylan Institutional LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20140328

FDA application: ANDA090212

## Active ingredients

- ADENOSINE: 3 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67457-856"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67457-856
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23e5c868-944f-4cc8-887f-9a2dc811af92